Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HBsAg Loss Adding Pegylated Interferon Alfa-2a in HBeAg-negative Patients Treated With Nucleos(t)Ide Analogues.

NCT02743182 is registered in ClinicalTrials.gov with José Antonio Carrion as lead sponsor.

NCT NCT02743182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02743182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HBsAg Loss Adding Pegylated Interferon Alfa-2a in HBeAg-negative Patients Treated With Nucleos(t)Ide Analogues.
Lead sponsor
José Antonio Carrion
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2015
Completion date
November 30, 2018
Enrollment
119 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b (hbeag-negative)